Alpha 1-Antitrypsin
Sponsors
Virginia Commonwealth University, Soroka University Medical Center, Massachusetts General Hospital, University of Minnesota, John Levine
Conditions
Acute Myocardial InfarctionAlpha 1-Antitrypsin DeficiencyGVHDGraft-versus-host-diseaseKidney TransplantPancreatitis, Chronic; Diabetes; TransplantPost Cardiac Surgery Systemic Inflammatory ResponseType 1 Diabetes
Phase 1
Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction
CompletedNCT01936896
Start: 2013-12-31End: 2014-07-31Updated: 2016-02-12
Single Dose Administration of Alpha-1 Anti-Trypsin for the Amelioration of Organ Injury in Patients Undergoing Cardiac Surgery
NCT02191839
Start: 2014-07-31End: 2015-07-31Target: 20Updated: 2014-07-16
Phase 2
Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant
CompletedNCT02464878
Start: 2017-01-31End: 2022-12-31Updated: 2023-12-22
A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD
CompletedNCT03459040
Start: 2018-08-17End: 2020-08-21Updated: 2021-07-12